Aquarius Population Health

How can economic models inform decision-making about screening programmes?

Dr Elisabeth Adams, Managing Director and Founder of Aquarius Population Health, spoke at a continuing medical education webinar for health professionals hosted on September 23,2020 by the Consortium for Infectious Disease Control (CIDC).   With increasing demands on time and resources, decision-makers in healthcare need information about how to create a safe, effective and cost-effective Read More >

Evaluating the use AMR POCT in treatment of gonorrhoea

Point-of-care tests for STI

Aquarius Population Health recently worked with the Applied Diagnostic Research & Evaluation Unit (ADREU) at St. Georges, University of London, to assess the cost-effectiveness of six hypothetical strategies for using antimicrobial resistance point-of-care testing to guide the treatment of gonorrhoea.  Our findings were presented at the STI & HIV World Congress in Rio de Janeiro, Read More >

Evaluating multi-bug point-of-care tests for sexually transmitted infections

Evaluating multi-bug point-of-care tests for sexually transmitted infections

We were a collaborator on a recent Innovate UK-funded SBRI project with Binx and the Applied Diagnostic Research and Evaluation Unit at St George’s University of London. In this project, our team compared the overall costs, patient benefits and cost-effectiveness of three different multi-pathogen point-of-care testing strategies with the current strategy of microscopy and lab-based Read More >

Antimicrobial resistance point-of-care test for gonorrhoea

In a study commissioned by the Review on Antimicrobial Resistance, Aquarius Population Health worked with modellers at the University of Bristol to create a mathematical model. The model was used to assess the economic implications and treatment impact of introducing a hypothetical antimicrobial resistance (AMR) point-of-care test (POCT) for gonorrhoea. Results of the study were Read More >

Antimicrobial resistance: Why it matters

Antimicrobial Resistance

Antimicrobial resistance (AMR) has been described as one of the world’s greatest threats to human and animal health. Some reports suggest that by 2050, AMR could kill around 10 million people each year worldwide.  Public health leaders warn we could enter a ‘post-antibiotic’ era where easily treatable common infections become untreatable.